```markdown
# Recital 147

## Overview

It is appropriate that the Commission facilitates, to the extent possible, access to testing and experimentation facilities to bodies, groups or laboratories established or accredited pursuant to any relevant Union harmonisation legislation and which fulfil tasks in the context of conformity assessment of products or devices covered by that Union harmonisation legislation. This is, in particular, the case as regards expert panels, expert laboratories and reference laboratories in the field of medical devices pursuant to Regulations (EU) 2017/745 and (EU) 2017/746.

### Related Article

View the [official text](https://eur-lex.europa.eu/legal-content/EN/TXT/HTML/?uri=OJ:L_202401689). The text used in this tool is the ‘[Artificial Intelligence Act (Regulation (EU) 2024/1689), Official version of 13 June 2024](https://eur-lex.europa.eu/legal-content/EN/TXT/HTML/?uri=OJ:L_202401689)’.

---

## Recital Text

**Recital 147**

It is appropriate that the Commission facilitates, to the extent possible, access to testing and experimentation facilities to bodies, groups or laboratories established or accredited pursuant to any relevant Union harmonisation legislation and which fulfill tasks in the context of conformity assessment of products or devices covered by that Union harmonisation legislation. This is, in particular, the case as regards expert panels, expert laboratories and reference laboratories in the field of medical devices pursuant to Regulations (EU) 2017/745 and (EU) 2017/746.

---

## Related Articles

*   [Article 43: Conformity assessment](/en/ai-act/article-43)

---

## Contact Us

*   [Contact the AI Office](mailto:CNECT-AIOFFICE@ec.europa.eu)
```